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SUMMARY
Association studies have been widely used to identify genetic liability variants for complex diseases.
While scanning the chromosomal region 1 single nucleotide polymorphism (SNP) at a time may not fully
explore linkage disequilibrium, haplotype analyses tend to require a fairly large number of parameters,
thus potentially losing power. Clustering algorithms, such as the cladistic approach, have been proposed
to reduce the dimensionality, yet they have important limitations. We propose a SNP-Haplotype Adap-
tive REgression (SHARE) algorithm that seeks the most informative set of SNPs for genetic association
in a targeted candidate region by growing and shrinking haplotypes with 1 more or less SNP in a step-
wise fashion, and comparing prediction errors of different models via cross-validation. Depending on
the evolutionary history of the disease mutations and the markers, this set may contain a single SNP or
several SNPs that lay a foundation for haplotype analyses. Haplotype phase ambiguity is effectively ac-
counted for by treating haplotype reconstruction as a part of the learning procedure. Simulations and a data
application show that our method has improved power over existing methodologies and that the results
are informative in the search for disease-causal loci.
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1. INTRODUCTION
Owing to the availability of high-throughput genotyping technologies and the comprehensive coverage of
common genetic variants by the HapMap project (The International Hapmap Consortium, 2005, 2007),
association studies are widely used to dissect the genetic basis of complex diseases in a scope varying
from a number of candidate genes to the whole genome. A typical association study involves initial pri-
oritization of single nucleotide polymorphism (SNP) genotypes in a small subsample or a selection of
tagSNPs derived from an existing database such as the HapMap project. These tagSNPs are subsequently
genotyped for a sample of cases and controls (Smith and others, 2007). While the causal variants may
not be interrogated directly, it is hoped that linkage disequilibrium (LD) mapping could narrow the search
down to a small neighborhood around the causal variants. However, despite the explosion of genetic in-
formation available, challenges remain for statistical analyses due to the diversity of LD patterns in the
human genome (The International Hapmap Consortium, 2005), the sheer number of SNPs being geno-
typed, and the complex nature of common disorders. Currently, the single-SNP scan and multiple-SNPs
haplotype analyses are 2 commonly used approaches. The power comparison between these 2 approaches
is somewhat inconclusive, as it depends on underlying disease models and local LD patterns (Morris and
Kaplan, 2002; Roeder and others, 2005). It has been suggested that a single-SNP scan is an effective
method to detect common disease alleles, while haplotype-based methods are useful to map more recent,
relatively rare mutations (Lin and others, 2004; Schaid, 2004), though strategies to construct informa-
tive haplotypes (clusters) are far from mature. This paper pertains to adaptive SNP/haplotype analysis
exploiting LD among SNPs in a candidate chromosomal region.
WhenmanySNPsinatargetedchromosomalregionareunderinvestigation,anaivehaplotypeanalysis
using all SNPs is often ineffective due to the large number of haplotypes and hence too many degrees
of freedom in an omnibus test. Instead, one may ﬁrst dividing SNPs into haplotype blocks of high LD
and then performing a haplotype analysis in each block (Barrett and others, 2005). However, the block
deﬁnition itself is arbitrary, and typically, there is substantial correlation not captured between blocks. An
alternative strategy is to construct a genealogical tree of haplotypes, known as a cladogram, and study the
correlation between the disease phenotype and the clusters (clades) of haplotypes, thereby reducing the
dimensionality of haplotype analyses (Templeton and others, 1987; Seltman and others, 2001; Molitor
and others, 2003; Durrant and others, 2004; Morris, 2006). The motivation is that the causal allele should
be embedded within the cladogram that describes the evolution of the sampled chromosomes. However,
an accurate construction of the underlying cladogram typically relies on the assumption that there is
no recombination. This is hardly true for any given region because of background recombination in the
human genome, particularly for regions near or within recombination hot spots. To this end, a sliding
window approach was proposed in the hierarchical clustering algorithm called CLADHC (Durrant and
others, 2004), yet the optimal window size cannot be universal due to the diversity of local LD through
the human genome. Even in an extreme scenario with complete LD, it was pointed out that cladistic
approaches cannot be optimal in all disease models (Clayton and others, 2004) since the rule of clustering
haplotypes is based solely on genotypic data.
Other strategies for multilocus analyses exist (e.g. Browning, 2006; Yu and Schaid, 2007; Li and
others, 2007). These methods generally assume that local LD structures are somewhat contiguous, thus
the order of SNP locations is critical. It is possible that SNPs that are separated apart can display strong
LD, so a contiguous scan might miss signals. Similarly, multiple nonsynonymous mutations in a gene may
disrupt the function of its coded protein jointly, possibly with interactions, regardless of their order in the
chromosome. Furthermore, all aforementioned methods do not account for extra variability incurred by
phase ambiguity in the model searching process, except the computationally intensive MCMC approach
(Morris, 2006).
In this article, we propose SNP-Haplotype Adaptive REgression (SHARE), an adaptive algorithm that
searches for a subset of SNPs, which fully capture genetic association in a candidate chromosomal region.682 J. Y. DAI AND OTHERS
The selected set of SNPs is the most informative in a heuristic sense: adding more SNPs introduces noise
and excluding any SNP in the set may lose information. Contrary to the cladistic approaches, where the
clustering process depends solely on haplotypes, in our algorithm, both the trait and the genotypes guide
the model selection process, and the SNP selection is irrespective of the order of the SNPs. Depending on
the genealogy and the ancestral recombination among disease liability mutations and markers, the most
informative set may contain a single SNP or several SNPs that lay a foundation for haplotype analyses,
thereby effectively integrating a single-locus scan and a haplotype analyses into 1 uniﬁed framework.
Furthermore, our algorithm stands apart from existing methods in that it accommodates phase ambiguity
seamlessly by treating the inference of haplotypes as part of the procedure. The method is tailored to
genetic association studies with a fair number of tagSNPs genotyped in a candidate gene approach, but,
as we address in the Section 4, it can be extended to genome-wide association studies.
2. METHODS
2.1 Rationale
We use an example to introduce the main idea: there generally exists a subset of SNPs that are sufﬁ-
cient to capture genetic association. Figure 1 shows the genealogical tree of 5 genptyped SNPs, labeled
as ABCDE, and the unscored disease susceptibility SNP X. The genotyped SNPs can be tagSNPs that
preserve maximal LD information with minimum redundancy. The haplotypes based on all 6 SNPs are
displayed as strings of 0s and 1s, labeled numerically. Depending on where the susceptibility SNP arise,
different subsets of SNPs are required to differentiate haplotypes that do and do not carry disease risk. In
Figure 1(a), X occurs before A in lineage, thus only 1 SNP (A) is sufﬁcient to capture the disease risk.
In Figure 1(b), the functional variant X descended from 2, generating a new haplotype that parallels 5
and 6 in lineage. We recognize that, instead of including all haplotypes based on 5 SNPs in an analysis,
if we restrict the haplotype analysis to A, D, and E, haplotype 100 carries an increased disease risk,
while all other haplotypes do not. In this case, a cladistic approach will collapse 2, 5, and 6 and therefore
dilute the disease signal. In the presence of recombination, the adjacent SNPs could have different ge-
nealogies. Thus, the genealogy of a sample of haplotypes is usually a graph with loops rather than a tree.
Figure 1(c) depicts a situation where there is recombination between 6 and 3, occurring between the fourth
and the ﬁfth locus. A new haplotype recombinant 8 is created. The functional variant X later arose in 6.
Fig. 1. An example to show that there generally exists an optimal set of SNPs for association analysis. The order of
SNPs in a haplotype is ABCDE(X). (a) The disease-causal locus X occurs before A in lineage. The optimal set for
genetic association is just A. (b) The disease-causal locus X occurs after A and in parallel to D, E. The optimal set
for genetic association is A, D, E. (c) The disease-causal locus X occurs after E in lineage. There is recombination
between haplotypes 6 and 3, generating a recombinant 8. The vertical arrow on the top of haplotype 8 points to the
break point of recombination. The optimal set for genetic association contains A, E or B, E.SHARE: an algorithm to select the most informative set of SNPs for association 683
An inspection of SNPs before and after the breaking point suggests that either A and E or B and E will
be adequate to discern the normal and risk-carrying haplotypes. For example, if we use SNP A and E to
construct haplotypes, the haplotype 11 carries increased disease risk, while the other 3 haplotypes do not.
This example sheds light on the effect of ancestral recombination on association mapping: it weakens the
LD between the functional variant and the “proxy” in its lineage; in consequence, haplotypes across the
breaking point become useful in mapping the functional variant. This is in the same spirit of the previous
results that long haplotypes cross the recombination breaking point can help to map recent rare mutations
(Lin and others, 2004). Note that the SNPs selected in Figure 1 are those before and after the functional
variant in evolution, thus forming an evolutionary pocket surrounding the disease variant.
To ﬁnd the most informative set, ideally, we would search all possible subsets of the available SNPs
using, for example, the generalized Akaike information criterion,
AICa =− 2  + ap, (2.1)
where   is the likelihood for a model, a is a penalty parameter, and p is the number of parameters in the
model. The best penalty parameter can be chosen by cross-validation. In reality, however, searching in all
possiblesubsetsquicklybecomesinfeasibleasthenumberofSNPsgetslargerthan20.Weinsteadpropose
a stepwise algorithm to identify the most informative set. That is, we sequentially select the current best
set by adding/deleting 1 SNP at a time to the previous best set, therefore substantially simplifying search
paths. While stepwise algorithms have limitations, in the genetic context where LD structure is present
in adjacent SNPs, stepwise selection is a natural choice, as opposed to more elaborative searching. The
rationale is that the fundamental unit of inheritance—the haplotype is formed by sequential (stepwise)
mutations during the history. Recombination shufﬂes around the haplotypes at breaking points (like hot
spots),butthemajorityofgenomicregionsshouldbehighlystructured.Withthenearlycompletecoverage
of whole-genome common variations by the HapMap project, it is hard to imagine that an underlying
disease loci does not exhibit any extra marginal association at all.
Different from a stepwise logistic regression treating SNPs as covariates (Cordell and Clayton, 2002),
our algorithm iteratively constructs haplotypes based on the SNPs in current set. If we consider the sam-
ple space a population of haplotypes, our algorithm resembles recursive partitioning (Classiﬁcation and
regression tree [CART]; Breiman and others, 1984). We use the example in Figure 1(b) to illustrate this
point. In Figure 1(b), a 3-SNP haplotype is best to capture the disease risk. One potential search path
shown in Figure 2 is that we ﬁrst ﬁnd SNP A as the most signiﬁcant SNP by a single-locus scan, next
detect haplotypes constructed by A and D as the best 2-SNP haplotypes, ﬁnally, we reach the most in-
formative set {A, D, E} so that a 3-SNP haplotype concentrates the disease risk. Note that adding 1 SNP
actually partitions the sample space of haplotypes. For any particular haplotype, it can be sent down the
tree just as an observation is being sent down in CART. While CART is effective to dissect high-order in-
teractions, growing haplotypes is essentially reﬁning high-order interactions between loci, as a haplotype
effect is a linear combination of locus main effects and high-order interactions (Schaid, 2004).
2.2 Notation
For ease of exposition, we consider a sample of n unrelated affected cases and unaffected controls. Con-
tinuous traits can be accommodated using the generalized linear model framework. Let Yi = 1i ft h eith
individual is a case and Yi = 0 otherwise, i = 1,2,...,n. Let Gi = (gi1,gi2,...,gik,...,giK) be the
SNP genotypes of individual i at K loci on some chromosomal region of interest, coded as 0,1,2 for the
number of the minor alleles at the kth locus. These SNPs could be tagSNPs selected to represent genetic
polymorphisms in the targeted region and some of them may be missing for some individuals. Suppose
that in addition to the genetic data, we also have information on r covariates Zi = (zi1,zi2,...,zir),
containing demographic and environmental factors.684 J. Y. DAI AND OTHERS
Fig. 2. The tree illustration of the sequential partition of haplotypes in Figure 1(b). The left panel shows the growing
set of SNPs used in analysis and the right panel shows the partitions resulted from the haplotypes based on the
current set of SNPs. The minimal set of SNPs that captures the genetic association is (A, D, E), with the disease risk
concentrated on the haplotype 100. The path leading to discovering it could be 1 → 10 → 100. The corresponding
order of SNPs in the haplotypes is A → AD → ADE.
Let  K denote the complete set of all K SNPs, and let  l denote the most informative set of l
SNPs that adequately captures the genetic association. By deﬁnition,  l ⊆  K and 0  l  K.
When l = 0,  l is an empty set, and there is no genetic association in the chromosomal region. Let
G k be the observed genetic data on a set  k. Assume that in the population, there are m distinct
haplotypes h k
1 ,h k
2 ,...,h k
m based on SNPs in  k, with (unknown) population frequencies p k =
(pl
1, pl
2,...,pl
m).I f k contains a single SNP, the haplotype is simply the genotype of the (single) lo-
cus. Hereafter, we generalize the deﬁnition of “haplotype” to include single-SNP genotypes. For the ith
individual, let H k
i ={ H k
i1 ,H k
i2 } be the haplotype pair based on  k. We assume that the underlying
probabilistic model describing the association, denoted as M(H k
i ,Zi),i s
logit[Pr(Yi = 1|G K
i ,Zi)] = α + β[ f (H k
i )] + γZi, (2.2)
where f (H k
i ) is a function that delineates the haplotype effect model, α is the intercept, and β and γ
are regression parameters for genetic and environmental effects, respectively. For instance, in an additive
model, f (H k
i ) represents a vector of m integers in {0,1,2} indicating the number for each of m pos-
sible haplotypes. In the dominant models, having 1 or 2 copies of a haplotype has the same effect. In
the recessive model, only having 2 copies of the causal haplotype will affect the trait. Gene–environment
interactions can be added to (2.2). For the observed data, we can compute the maximal likelihood esti-
mators of parameters in (2.2) and obtain   M(H k
i ,Zi). Note that we have genotypes for all SNPs ( K);
however, we only select a subset to be used in the regression model ( k). The best subset  l with its
associated model M(H l
i ,Zi) is selected by minimizing the prediction error. Let ˆ pi =   Pr(Y = yi)
be the probability of accurately predicting yi based on   M(H k
i ,Zi) when a new independent sub-
ject comes in. We deﬁne a loss function, namely deviance or cross-entropy (Hastie and others, 2001),
D(yi, ˆ pi) =− [yi log ˆ pi + (1 − yi)log(1 −ˆ pi)], that quantiﬁes the correctness of ˆ pi. Our goal was to
minimize the expected loss (or the expected prediction error) over  k to ﬁnd the best set  l. This can be
expressed as
 l = argmin k E{D(yi, ˆ pi|  M(H k
i ,Zi))}. (2.3)SHARE: an algorithm to select the most informative set of SNPs for association 685
2.3 The algorithm
If we search for the most informative set by 10-fold cross-validation estimates of the above objective
function, the algorithm is as follows:
1. For i = 1t o1 0 ,
• In the ith training set, grow a sequence of nested sets  0 ⊂  i1 ⊂  i2 ···⊂ iM, where M is
the largest number of SNPs in a candidate subset, speciﬁed by the investigator. Here  0 indicates
a model without any genetic effect.
• In the ith training set, prune  iM back 1 SNP at a time to obtain a sequence of nested sets
 iM ⊃  iM−1
  ⊃  iM−2
  ···⊃ 0 .
• In the ith training set, evaluate the prediction deviance for the models associated with  0 ⊂
 i1 ⊂  i2 ···⊂ iM ⊃  iM−1
  ⊃  iM−2
  ···⊃ 1
 .
2. Sum up the prediction deviances from the 10 cross-validations for each model path, choose the
number of SNPs, l, with the smallest prediction deviance.
3. Use all data to search for the model formed by l SNPs. If l was achieved in the growing stage, grow
the subset up to l SNPs; If l was achieved in the pruning stage, grow the subset up to M SNPs and
prune back to l SNPs.
Let m t be the number of haplotypes given the current best subset  t with t SNPs. Starting from the
best single SNP, we select the next best subset containing t +1 SNPs,  t+1, with the maximal statistic φ,
deﬁned as
φt+1 =
⎧
⎪ ⎨
⎪ ⎩
D t −D t+1
m t+1−m t
if m t+1  = m t,
0 otherwise.
(2.4)
This involves ﬁtting regression model (2.2) to each candidate subset, computing the maximal likelihood,
and evaluating the φ statistic. Note that the statistic φ incorporates both the information from the LD
between SNPs and the regression of the trait on the SNPs. If adding 1 SNP does not increase the number
of unique haplotypes, that is the new SNP is in perfect LD with the rest of SNPs, there is no contribution in
model ﬁtting and thus φ equals 0. The maximum of φt+1 represents the largest penalty parameter in AICa
(2.1), so that the model with 1 extra SNP is still preferable. For all a < max(φt+1), the set associated with
max(φt+1) has the minimal AICa among all candidate sets with t + 1 SNPs.
If the best model size is 0, there appears to be no genetic association in the region of interest. The lower
the prediction deviance of the ﬁnal model compared with the null model, the more likely the association.
To assess signiﬁcance of the associations, we perform a permutation test to correct the over-optimism
incurred by the greedy model searching process. We ﬁrst compute a nominal p value for the global hap-
lotype effect in the ﬁnal model using a Wald test. We then permute the trait 1000 times regardless of the
genotypic data, carry out model searching for each permuted data set, and compute the nominal p value
using a Wald test. When environmental factors are present, we permute the trait within the strata deﬁned
by environmental factors. Finally, the experimentwise p value is computed by comparing the observed p
value to its null distribution.
When the haplotype phase is unknown, as is usually the case, our algorithm treats phasing as a part
of the learning procedure. The full-scale haplotype phasing is carried out only once using all SNPs under
investigation to obtain the maximal resolution. Because each training data consist of 9/10 full data, the
haplotype frequencies estimated from each training set are usually a slight modiﬁcation of those estimated
from the full data and hence can be computed rather quickly by an Expectation-Maximization algorithm686 J. Y. DAI AND OTHERS
(Excofﬁer and Slatkin, 1995). One can have multiple pairs of possible haplotypes, each pair has an esti-
mated conditional probability given all genotypes. For a model associated with  k, the expected deviance
for a subject can be expressed as follows:
E[D k
i |G K
i ] =−
 
H k
i ∈G K
i
  Pr(H k
i |G K
i ,p K )log[Pr(Yi|H k
i ,Zi)], (2.5)
where   Pr(H k
i |G K
i ,p K ) is the estimated conditional probability of the haplotype pair for the SNPs
in the model given the all genotypes. For each H k
i , this conditional probability is equal to the sum of a
collection of   Pr(H K
i |G K
i ,p K ) since each haplotype formed by  k represents a cluster of haplotypes
formed by  K. For the ﬁnal model, robust sandwich variance estimates are used to compute the nominal
p value. Note that under the null hypothesis that there is no genetic effect, the estimation of haplotype
frequencies is independent of the estimation of the regression parameters, so using a sandwich variance
estimate yields a valid test for any global genetic effect.
The core of the SHARE algorithm is written in C with an R interface. An R-package can be down-
loaded from the ﬁrst author’s homepage: http://www.scharp.org/faculty/jdai as well as CRAN (The Com-
prehensive R Archive Network). Currently, a model searching process for for settings with 10–30 SNPs
and 2000 subjects takes about half a second on a Dell workstation with a 3.0-GHz processor. In situations
where the best model after selection is the null model, no permutation test is required as this clearly in-
dicates nonsigniﬁcance. Otherwise, the permutation test can be speeded up by giving up early on clearly
nonsigniﬁcant results (Besag and Clifford, 1991).
3. RESULTS
3.1 Simulations
The details of the simulations are in the Biostatistics online supplementary document. We compared the
empirical type I errors and the power of detecting the global genetic effect in the simulated chromosomal
region when a hypothesis test is performed with a type I error of 0.05. As benchmarks of our compar-
ison, we used the single-locus scan and the naive haplotype analysis using all SNPs, assuming known
phase. The haplotype score test (Schaid and others, 2002) was included for evaluating the impact of hap-
lotype ambiguity when model selection is not employed. We used CLADHC as an example of cladistic
approaches in the comparison. The window size for CLADHC is set to 6 SNPs throughout simulations.
We performed the SHARE analysis with and without knowing haplotype phase, with the maximal num-
ber of 6 SNPs in the candidate sets and 10-fold cross-validation. For all methods except the 2 using full
haplotypes, permutation tests were used to correct for multiple testing.
We ﬁrst simulated 2 disease models using the empirical haplotype frequencies of the F11 gene in the
PGA database. Among the 45 SNPs in this gene, 11 tagSNPs (2, 3, 5, 6, 9, 11, 22, 24, 30, 42, and 45) are
observed in 800 cases and 800 controls. For our ﬁrst model, we simulated an unscored functional variant,
which has a minor allele frequency (MAF) around 0.05 and is strongly tagged by 2 tagSNPs. Table 1
displays the haplotype frequencies formed by the 3 SNPs. Both tagSNPs 3 and 5 are correlated with SNP
12, and the haplotype 11 formed by these 2 SNPs perfectly predicts SNP 12. When an additive disease
risk is added to SNP 12 using a logistic penetrance function with odds ratios (ORs) 1.5, 1.75, and 2.0, it is
anticipated that a haplotype analysis that is just using SNPs 3 and 5 will best capture the disease signal. In
theupperpanelofTable2,allmethodsyieldvalidtests,asthetypeIerrorsareallwithinareasonablerange
of0.05.Clearly,CLADHChastheworstpowersincetherecombinationbetweenSNP3andSNP5renders
it hard to construct a correct cladogram. There is a clear advantage of SHARE over the full haplotypeSHARE: an algorithm to select the most informative set of SNPs for association 687
Table 1. The ﬁrst model in simulations based on empirical data: 2 tagSNPs display strong LD with the
unscored causal locus. TagSNPs 3 and 5 are genotyped and SNP 12 is the unscored functional locus.
Haplotype 11 by SNPs 3 and 5 perfectly tagsSNP 12. The haplotype frequencies are estimated from 23
Americans of European descend in the PGA database
Haplotype/SNP351 2Haplotype frequency
1 0 0 0 0.847
2 0 1 0 0.087
3 1 0 0 0.022
41 1 1 0.044
Table 2. Simulations based on empirical data: a comparison of type I errors and power for various meth-
ods under 2 disease model in 500 simulations. Standard errors are given in parentheses. For the ﬁrst
model, we generate data for 800 cases and 800 controls with ORs 1.5, 1.75, and 2; for the second model,
we generate data for 400 cases and 400 controls with ORs 1.25, 1.5, and 1.75
Method Type I error Power
OR = 1.5 OR = 1.75 OR = 2
Model 1† Single-locus scan 0.048 (0.010) 0.318 (0.015) 0.648 (0.015) 0.914 (0.013)
Phase known Full haplotype 0.052 (0.010) 0.284 (0.020) 0.590 (0.022) 0.870 (0.015)
CLADHC 0.056 (0.010) 0.256 (0.020) 0.546 (0.022) 0.854 (0.016)
SHARE 0.050 (0.010) 0.336 (0.021) 0.654 (0.021) 0.928 (0.012)
Phase unknown Haplotype score 0.035 (0.008) 0.288 (0.020) 0.544 (0.022) 0.863 (0.015)
SHARE 0.054 (0.010) 0.326 (0.021) 0.650 (0.021) 0.900 (0.013)
OR = 1.25 OR = 1.5 OR = 1.75
Model 2‡ Single-locus scan 0.046 (0.007) 0.176 (0.017) 0.608 (0.015) 0.916 (0.012)
Phase known Full haplotype 0.046 (0.009) 0.184 (0.017) 0.616 (0.022) 0.920 (0.012)
CLADHC 0.062 (0.011) 0.138 (0.015) 0.548 (0.022) 0.882 (0.014)
SHARE 0.046 (0.009) 0.182 (0.017) 0.678 (0.021) 0.952 (0.010)
Phase unknown Haplotype score 0.050 (0.010) 0.158 (0.016) 0.586 (0.022) 0.900 (0.013)
SHARE 0.044 (0.009) 0.190 (0.018) 0.666 (0.021) 0.942 (0.010)
†The unscored disease-causing locus is best captured by haplotypes based on 2 tagSNPs.
‡Two tagSNPs separated apart carry disease risk additively.
analysis because of SNP selection. SHARE only slightly outperforms the single-locus scan since the r2
between tagSNP 3 and SNP 12 is fairly high (0.63). Among the ﬁnal models selected by SHARE with
p < 0.05, the median size of the best SNP set is 2. Approximately one-third of the signiﬁcant models
contain only 1 SNP, again because of the marginal correlation between tagSNP 3 and SNP 12. When
the full haplotype test assuming phase is known and the score test with phase ambiguity are compared,
it is seen that phase ambiguity diminishes the power by at most 5% (for OR = 1.75). Less impact from
haplotype ambiguity was observed for SHARE. The reason is that model selection leads to far fewer SNPs
being used in the ﬁnal association and hence far less haplotype ambiguity needs to be resolved.
For the second model, we simulated 2 tagSNPs (5, 45) contributing independently, rather than through
a haplotype effect, to the disease risk. TagSNP 5 has MAF 0.13 and tagSNP 45 has MAF 0.087. The
disease risk was imposed via a logistic function with ORs 1.25, 1.5, and 1.75. We generated 400 cases
and 400 controls. The bottom panel of Table 2 reveals that SHARE yields the best power regardless688 J. Y. DAI AND OTHERS
of whether the phase is known or not. The cladistic approach has the worst power because a moving
window of 6 SNPs will not cover both tagSNP 5 and tagSNP 45. However, a longer window does not
help much since it is more likely to introduce recombination among SNPs. Neither the single-locus scan
nor the full haplotype analysis outperforms SHARE since the single-locus scan does not combine the
effects from the 2 loci and the full haplotype analysis uses too many parameters. Again phase ambiguity
does not substantively impact the power of SHARE. Due to the small sample variation, SHARE with
phase ambiguity seems to outperform SHARE without phase ambiguity when OR is 1.25, although this
improvement is not statistically signiﬁcant.
We now evaluate the performance of SHARE on average in a variety of models generated by sampling
haplotypes based on coalescence theory (Hudson, 2002) and randomly assigning 1 relatively rare SNP
(with MAF ≈ 0.05) to carry the disease risk. Table 3 shows the comparison of type I error and power
for the various methods more than 500 simulations. The recombination rates are set to reﬂect regions
with background recombination rate and regions with high recombination rate, such as the regions near or
within hot spots. When the LD is high, the median number of common haplotypes is nearly the same as the
number of tagSNPs. Because the disease locus is left out before tagSNP selection, the average maximalr2
between any tagSNP and the underlying disease locus is merely 0.36, and in only 12% of the simulations,
the maximal r2 between tagSNPs and the underlying disease locus is larger than 0.8. In this case, the
haplotype-based methods generally yield higher power than the single-locus scan, particularly when the
signal is strong (OR = 2). CLADHC performs only slightly better than the naive full haplotype approach.
It appears that not every tagSNP is necessarily useful in detecting association, as SHARE outperforms all
other methods, having 5–15% more power, particularly when the OR is more than 1.75. Since the LD is
strong, haplotype ambiguity has little effect on power even for the naive haplotype analysis. On the other
hand, the lower half panel in Table 3 suggests that the high recombination rate drastically reduces the
power for all methods considered. The average maximal r2 between tagSNPs and the underlying disease
Table 3. Simulations based on coalescence by ms: a comparison of type I errors and power for various
methods in 500 simulations. Standard errors are given in parentheses. The high and low LD represent
recombination rate per site per generation of 10−9 and 10−7, respectively. The sample consists of 1000
cases and 1000 controls
LD[#SNP†,#Hap‡] Method Type I error Power
OR = 1.5 OR = 1.75 OR = 2
High[15,16] Single-locus scan 0.052 (0.010) 0.254 (0.019) 0.416 (0.022) 0.592 (0.022)
Phase known Full haplotype 0.050 (0.010) 0.242 (0.019) 0.456 (0.022) 0.648 (0.021)
CLADHC 0.042 (0.009) 0.246 (0.019) 0.464 (0.022) 0.678 (0.021)
SHARE 0.050 (0.010) 0.312 (0.021) 0.548 (0.022) 0.728 (0.020)
Phase unknown Haplotype score 0.034 (0.008) 0.216 (0.018) 0.462 (0.022) 0.664 (0.021)
SHARE 0.050 (0.010) 0.308 (0.021) 0.528 (0.022) 0.738 (0.020)
Low[15,30] Single-locus scan 0.038 (0.009) 0.154 (0.016) 0.316 (0.021) 0.420 (0.022)
Phase known Full haplotype 0.040 (0.009) 0.116 (0.014) 0.232 (0.019) 0.370 (0.022)
CLADHC 0.044 (0.009) 0.146 (0.016) 0.328 (0.021) 0.510 (0.022)
SHARE 0.042 (0.009) 0.174 (0.017) 0.382 (0.022) 0.516 (0.022)
Phase unknown Haplotype score 0.032 (0.009) 0.084 (0.012) 0.148 (0.016) 0.322 (0.021)
SHARE 0.048 (0.010) 0.160 (0.016) 0.354 (0.021) 0.498 (0.022)
† The median number of tagSNPs in 500 simulated data.
‡ The median number of common haplotypes in 500 simulations. The common haplotypes are deﬁned as those with frequencies
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locus is only 0.25, and in only 4.4% simulations, the maximal r2 between tagSNPs and the underlying
disease locus exceeds 0.8. The full haplotype method yields much lower power than the single-locus
scan because of the increased number of haplotypes. Although SHARE retains the best power power,
the advantage over CLADHC is not as large as in the high LD scenario, suggesting that there is limited
LD structure to be exploited in regions across recombination hot spots. Contrary to a naive haplotype
analysis, there is little effect of phase ambiguity on the performance of SHARE in this scenario. Note that
the power shown in Table 3 is the average of 500 different models. Overall, the model selection procedure
by SHARE has more power than the other approaches, particularly in regions with high LD.
3.2 Data application
We used SHARE to re-analyze the data from a published case–control genetic association study (Smith
and others, 2007). This study aimed to investigate the association of common genetic variation in 24
coagulation, anti-coagulation, ﬁbrinolysis, and antiﬁbrinolysis candidate genes with risk of incident non-
fatal venous thrombosis in postmenopausal women. The participants were selected from a large integrated
health care system in Washington State and consist of 349 cases and 1680 controls matched on age, hy-
pertension status, and calendar year. In the original analysis, the single-locus scan and a full haplotype
analysis were applied to each of 24 genes, assuming an additive genetic effect, adjusting for race and other
matching variables (e.g. age and hypertension status). We illustrate our algorithm using the data on the
tissue factor pathway inhibitor (TFPI) gene. The LD among ﬁve genotyped tagSNPs in TFPI gene is quite
strong and the highest correlation occurs between 2 adjacent tagSNPs: rs2192824 and rs2300412
(r2 = 0.4). This region has been shown to have a signiﬁcant global haplotype effect (Smith and oth-
ers, 2007). Figure 3 shows prediction deviances, estimated by 10-fold cross-validation, of various models
Fig. 3. The prediction deviances of different models for the TFPI gene. The horizontal axis is the number of SNPs
included in the sequence of best subsets when model growing and pruning. The horizontal dashed line on the top
represents the deviance of a null model without considering genetic effect. The vertical dashed line indicates the
switch from model growing to pruning. The deviance is calculated from a model with haplotypes constructed from
SNPs in the set. The lower the deviance is interpretted as better the model prediction.690 J. Y. DAI AND OTHERS
Table 4. The results of a SHARE analysis on 5 SNPs in the TFPI gene. SNPs 1–5 are rs2192824,
rs2300412, rs8176597, rs8176612, and rs3771059, respectively. The left table shows 10
haplotypes using all 5 SNPs in the analysis. The right table shows that using SHARE, the association was
narrowed down to haplotypes based on rs2192824 and rs2300412
Haplotype12345Frequency
1 00000 0.2254
2 00001 0.0018
3 00010 0.0002
4 01000 0.0593
5 01001 0.2644
6 01010 0.0003
7 01100 0.0515
8 10000 0.2989
9 10001 0.0376
1 0 10010 0.0605
Haplotype 1 2 Frequency OR (95% conﬁdence interval)
I 0 0 0.227 —
II 0 1 0.376 1.28 (1.02, 1.63)
III 1 0 0.397 1.43 (1.16, 1.87)
with different sets of SNPs. Lower deviances suggest better prediction accuracy. It is clear that there
is a genetic effect in this gene as all models yield a smaller prediction deviance than the null model.
We performed a permutation test within the strata deﬁned by other covariates. The p value for a global
null hypothesis is 0.023. It is interesting to observe that though SNP rs2192824 predicts the disease
status fairly well, a haplotype model based on SNPs rs2192824 and rs2300412 further improves
the prediction accuracy; inclusion of additional tagSNPs no longer helps. Inspection of the haplotype
analysis using SNPs rs2192824 and rs2300412 (Table 4), we found that the increased disease risk
is concentrated on haplotypes “01” and “10.” This pattern implies that there might be an underlying
disease-causing allele that is tagged by these 2-SNP haplotypes. We searched the SeattleSNPs database
for SNPs that are not genotyped in the study. Based on 23 European descended individuals, there is a
total of 54 SNPs with MAF larger than 0.05, covering a distance of 3.9 kb in this region. We found 2
SNPs (rs8676500 and rs8176531), that are in perfect LD with each other, which display a pattern
of correlation to rs2192824 and rs2300412 similar to the results in the SHARE analysis. The high-
est pairwise r2 between scored SNPs and unscored SNPs is 0.17, however, if we deﬁne a multilocus r2
as in Hao and others (2007), the highest r2 jumps to 0.72. Both rs8676500 and rs8176531 are lo-
cated in the intron region of the TFPI gene. Although it is too early for an interpretation on this ﬁnding,
this analysis gives useful hints for future studies, such as genotyping more SNPs that are correlated with
rs2192824 and rs2300412 such as rs8676500 and rs8176531.
This data example shows a further beneﬁt beyond the power enhancement that we focused on in
the simulations: a parsimonious model with fewer SNPs helps us hunt for the “true” underlying “causal”
mutation. The naive haplotype analysis using all 5 tagSNPs yields signiﬁcant association for a global
genetic effect, yet it is not clear how to pursue this analysis further based on all 10 haplotypes (shown
in Table 4). On the other hand, if we are willing to take the most likely haplotype pair for subjects with
haplotype phase ambiguity, we can perform a CLADHC analysis, which here suggests that the best par-
tition of 10 haplotypes is formed by 2 clusters: a cluster with haplotypes 8 and 9 and a cluster with the
remaining haplotypes. However, it is not clear how to interpret and follow-up these clusters by CLADHC.
4. DISCUSSION
Many strategies have been proposed to perform haplotype-based multilocus analyses. The majority focus
on how to cluster haplotypes given a set of predeﬁned SNPs. There are a few attempts to select SNPsSHARE: an algorithm to select the most informative set of SNPs for association 691
that form haplotypes. For instance, to evaluate the coverage of the Affymetrix GeneChip and Illumina
BeadChip on the HapMap project data, Pe’er and others (2006) used multimarker predictors that capture
an additional 9–25% of SNPs in the ENCODE region or in the HapMap Phase II data. The search for
multimarker predictors is limited to those SNPs with strong LD. Alternatively, it has been proposed to
exhaustively search for windows of contiguous SNPs that form haplotypes (Lin and others, 2004). The
computational burden can be insurmountable for large regions and it is not clear whether only considering
contiguous SNPs in a window is an effective strategy. In this article, we propose a novel strategy to select
the most informative set of SNPs which in turn forms the basis for haplotype analysis. The advantage
of the SHARE algorithm is its adaptivity: it exploits both the LD structure and the underlying disease-
generating mechanism, and the addition or deletion of SNPs is noncontiguous. In a variety of simulation
settings, SHARE consistently outperforms other existing methods.
Imputation procedures have been shown to be useful to capture the association of a phenotype and
unmeasured genotypes (e.g. Nicolae, 2006; Servin and Stephens, 2007). Rather than choosing haplotypes
that “tag” untyped variants, as implemented in the SHARE algorithm, these procedures impute the “miss-
ing” (untyped but known) variants based on the LD estimated from public databases (e.g. the HapMap
project). For common alleles already cataloged in these databases, the imputation procedures would likely
be powerful since they incorporate external information. For rare alleles (MAF  5%), the imputation
methods could miss the signal (depending on the size of the database), while our method may still cap-
ture it by constructing rare haplotypes. Furthermore, if there are multiple loci with interaction effects on
a disease phenotype, for example multiple nonsynonymous mutations, a haplotype analysis with model
selection can be useful to integrate the joint and interactive effects of the multiple loci.
Our method is motivated, but not limited by candidate gene studies. To scale our haplotype analyses
up to genome-wide association studies, our strategy is to ﬁrst divide the genome into long haplotype
blocks and perform an adaptive haplotype analysis in each block. We deﬁne blocks by long chromosomal
regions between recombination hot spots that may stretch several hundred kbs and contain a fair number
of tagSNPs (10 ∼ 50). This is rather a loose criterion compared with the deﬁnition of haplotype blocks
used in Gabriel and others (2002) or Wang and others (2002). In phase II of the HAPMAP project,
32,996 recombination hot spots were identiﬁed of which 68% are localized to a region of 5 kb. The
spacing between adjacent hot spots is 100–200 kb on average (The International Hapmap Consortium,
2007). Permutation test on the genome-wide level would be computationally demanding. However, it is
unnecessary since there should be at most a handful of blocks that suggest genetic association. In the
supplementary material (available at Biostatistics online), we discuss strategies to reduce the computation
in assessing genome-wide signiﬁcance. Further details to improve SHARE to a version that can deal with
genome wide association studies will be pursued in future work.
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